Is Big Pharma Bad? - Facts & Infographic

Last week, British Big Pharma company GlaxoSmithKline GSK -0.16% (GSK) announced plans to dramatically reform the way it sells and markets its drugs to doctors. For years now, drug makers have been operating on the dark side, financially incentivizing doctors and health care providers to promote their drugs, and compensating pharmaceutical sales reps based on the number of prescriptions written by the doctors they call on.

Spotlight

i3 Research

i3 is a global pharmaceutical services company that provides integrated strategies and solutions throughout the product lifecycle.i3 Advantage: Your i3 projects and staffing solutions will benefit from the many resources uniquely available to i3 through our corporate ties. i3 is a business unit of Ingenix, a wholly-owned subsidiary of UnitedHealth Group. Ingenix provides knowledge and information services Intelligence for Health Care to UnitedHealth Group businesses.

Other Infographics
news image

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More
news image

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Read More
news image

Pharmaceutical Industry World Economy Scenario

Infographic | May 20, 2022

This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.

Read More
news image

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Read More

Spotlight

i3 Research

i3 is a global pharmaceutical services company that provides integrated strategies and solutions throughout the product lifecycle.i3 Advantage: Your i3 projects and staffing solutions will benefit from the many resources uniquely available to i3 through our corporate ties. i3 is a business unit of Ingenix, a wholly-owned subsidiary of UnitedHealth Group. Ingenix provides knowledge and information services Intelligence for Health Care to UnitedHealth Group businesses.

Events